Infinity Pharmaceuticals, Inc. (INFI): $3.07

-0.04 (-1.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INFI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

Infinity Pharmaceuticals Inc (INFI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INFI.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $12 $4 $8.5 $3.32 156.02%

The Trend in the Analyst Price Target


Over the past 169 days, INFI's average price target has gone up $4.37.

Over the past 13 months, INFI's average upside potential has been 117.38%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 6 12.0 4 8.50 3.450 146.38%
2021-06-05 6 12.0 4 8.50 3.300 157.58%
2021-05-22 6 12.0 4 8.50 3.130 171.57%
2021-05-15 6 12.0 4 8.50 2.720 212.5%
2021-05-08 6 12.0 4 8.50 3.150 169.84%
2021-04-25 6 12.0 4 8.50 3.090 175.08%
2021-04-17 6 12.0 4 8.50 2.980 185.23%
2021-04-10 6 12.0 4 8.50 3.310 156.8%
2021-04-03 6 12.0 4 8.50 3.320 156.02%
2021-03-20 6 12.0 4 8.67 3.640 138.19%
2021-03-13 5 12.0 2 7.60 3.120 143.59%
2021-03-06 5 12.0 2 7.60 2.690 182.53%
2021-02-27 5 12.0 2 7.60 3.040 150%
2021-02-20 5 12.0 2 7.60 3.770 101.59%
2021-02-13 4 12.0 2 7.75 4.040 91.83%
2021-02-06 4 7.0 2 4.75 3.930 20.87%
2021-01-30 4 7.0 2 4.13 3.470 19.02%
2021-01-23 4 7.0 2 4.13 4.090 0.98%
2021-01-16 4 7.0 2 4.13 3.180 29.87%
2021-01-09 4 7.0 2 4.13 2.450 68.57%
2021-01-02 4 7.0 2 4.13 2.120 94.81%
2020-12-26 4 7.0 2 4.13 2.100 96.67%
2020-12-19 4 7.0 2 4.13 2.050 101.46%
2020-12-09 4 3.5 1 2.63 2.240 17.41%
2020-12-07 4 3.5 1 2.63 2.140 22.9%
2020-11-12 4 3.5 1 2.62 1.530 71.24%
2020-07-29 4 3.5 1 2.50 0.825 203.03%
2020-07-25 4 3.5 1 2.50 0.830 201.2%
2020-05-15 4 3.5 1 2.50 NA NA%

INFI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 1 4 2 0 0 7

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INFI as an investment opportunity.

  • Infinity Pharmaceuticals Inc's variance in analysts' estimates is less than 6.03% of all US stocks.
  • Infinity Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 90.47% of all US stocks.
  • INFI has a higher average analyst price target than 8.4% of stocks in the mid market cap category.
  • Infinity Pharmaceuticals Inc's number of analysts covering the stock is higher than 39.39% of stocks in the mid market cap category.

Stocks similar to Infinity Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KLDO, SPPI and PSTI.

Is INFI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7722 seconds.